Myocardial fibrosis and outcome in aortic stenosis: a CMR and circulating biomarker study

30 August 2025 (15:15 - 16:00)

Organised by:

Video

Sign in for access options

Abstract

Slides

About the speaker

Associate Professor Arantxa Gonzalez Miqueo

University of Navarra Clinic, Pamplona (Spain)

6 More presentations in this session

Presentation thumbnail

Cardiac damage stages and clinical outcomes in patients with severe aortic stenosis

Doctor Y. Takeji (Kanazawa, JP)

Abstract Slides Video

Presentation thumbnail

Evaluating the impact of left ventricular end-systolic elastance on aortic stenosis

Doctor E. Thong (Singapore, SG)

Abstract Slides Video

Presentation thumbnail

Comparative outcomes of early intervention vs. watchful waiting strategy for moderate aortic stenosis by extent of extra-valvular cardiac damage

Doctor J. Lim (Seoul, KR)

Abstract Slides Video

Presentation thumbnail

Prognostic impact of heart failure as an indication for intervention in severe aortic stenosis

Miss A. Cristea (Valladolid, ES)

Abstract Slides Video

Presentation thumbnail

Impact, prognostic implications and treatment trends of aortic stenosis across the heart failure spectrum

Doctor G. Heitzinger (Vienna, AT)

Abstract Slides Video

Access the full session

Session thumbnail

Myocardial damage and aortic stenosis: a close interplay

The Event

Event poster

ESC Congress 2025

30 August 2025 15:15 CET

You may be interested in

Congress Presentation

Limitations of traditional aortic stenosis classification: myocardial fibrosis across AS subtypes assessed by cardiac magnetic resonance.

Congress Session

Exploring valvular and congenital heart disease with cardiac magnetic resonance

Congress Session

Deep dive into aortic stenosis: new imaging insights

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources